Neptune Technologies & Bioressources Inc  

(Public, TSE:NTB)   Watch this stock  
Find more results for NTB
2.69
-0.02 (-0.74%)
Jul 11 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.65 - 2.69
52 week 2.41 - 4.35
Open 2.69
Vol / Avg. 39,814.00/94,150.00
Mkt cap 198.50M
P/E     -
Div/yield     -
EPS -0.27
Shares 73.79M
Beta 1.64
Inst. own     -

Key stats and ratios

Q1 (Feb '14) 2014
Net profit margin -36.22% -114.06%
Operating margin -36.48% -112.41%
EBITD margin - -103.69%
Return on average assets -6.42% -26.21%
Return on average equity 1.67% -31.30%
Employees 111 -
CDP Score - -

Address

Suite 200, 225 Promenade du Centropolis
LAVAL, QC H7T 0A3
Canada
+1-450-6872262 (Phone)
+1-450-6872272 (Fax)

Website links

Description

Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune�s distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company�s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).

Officers and directors

Ronald Denis Independent Chairman of the Board
Andre Godin Interim President and Chief Executive Officer, Chief Financial Officer
Fotini Sampalis M.D., Ph.D. Chief Global Strategy Officer
Henri Harland Director
Harlan W. Waksal M.D. Director
Age: 60
Daniel Perry Independent Director
Reed V. Tuckson M.D. Independent Director
Age: 48